Essex Bio-Technology's total assets for Q4 2025 were HK$3.49B, an increase of 7.95% from the previous quarter. HK:1061 total liabilities were HK$1.08B for the fiscal quarter, a 12.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.